Company Filing History:
Years Active: 1976-1977
Title: M Antoine Stenger: Innovator in Psychotropic Medicaments
Introduction
M Antoine Stenger is a notable inventor based in Castres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of psychotropic medicaments. With a total of 3 patents to his name, Stenger's work has the potential to impact the treatment of various psychological conditions.
Latest Patents
Stenger's latest patents focus on new chemical compounds that can be utilized as drugs, specifically for their psychotropic properties. One of his notable inventions involves medicaments that can be administered through various methods, including orally, rectally, parenterally, or locally. These compounds are designed to be effective either alone or in combination with other active principles. A key component of his research includes 5-Bromo-ortho-cresotamide, which is also referred to as 5-Bromo-2-hydroxy-3-methyl-benzamide. This compound has shown promise in enhancing the effects of aspirin.
Career Highlights
Stenger is associated with Pierre Fabre S.A., a company known for its commitment to innovation in the pharmaceutical industry. His work at Pierre Fabre has allowed him to explore and develop new therapeutic options that address mental health issues.
Collaborations
Throughout his career, Stenger has collaborated with esteemed colleagues such as Henri Cousse and Gilbert Mouzin. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
M Antoine Stenger's contributions to the field of psychotropic medicaments highlight his innovative spirit and dedication to improving mental health treatments. His work continues to pave the way for new therapeutic options in the pharmaceutical industry.